Representative · CA-1 · R
Current term Jun 10, 2026 – Jan 3, 2027 · In the House since Jun 10, 2026
Lobbying reports (LD-2) whose issue descriptions explicitly cite a bill this member sponsored, cosponsored, or cast a recorded vote on. This documents an overlap in subject only. LD-2 reports generally do not name the members contacted, and a citation does not show contact with this member, influence, or the client's position on the bill. No matching record means none was found within coverage, not that no lobbying occurred.
Loading lobbying reportsCoverage: LD-2 reports for 2025 onward, posted Jan 1, 2025 through Oct 27, 2026. Only the current version of each report is used.
6,282 report citations, newest first.
CINTAS · lobbying firm or registrant: CINTAS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Apparel/Clothing Industry/Textiles
$480,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded vote on 1 roll call
Reauthorization of Trade Preference Programs, including Haiti HOPE/HELP Acts (S. 742, H.R. 6504, and H.R. 1625) and the African Growth and Opportunity Act (H.R. 6500 and S. 2958); tariffs
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
SATOSHI ACTION FUND · lobbying firm or registrant: COGENT STRATEGIES LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Energy/Nuclear
$20,000
Paid to lobbying firm
CitesH.R. 8800· this member:Recorded votes on 21 roll calls
- Issues related to bitcoin mining. - S. 4251, Mined in America Act of 2026, and the House companion bill - H.R. 8800 and S. 4784, National Defense Authorization Act for Fiscal Year 2027
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CANDA SOLUTIONS · lobbying firm or registrant: RIDGE PATH STRATEGIES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$30,000
Paid to lobbying firm
CitesH.R. 8800· this member:Recorded votes on 21 roll calls
Government security solutions and clearance reform. Issues related to the National Defense Authorization Act (H.R. 8800, S. 2296).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
FOREST LANDOWNERS ASSOCIATION · lobbying firm or registrant: SCHOENING STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Taxation/Internal Revenue Code
$10,000
Paid to lobbying firm
CitesS. 629· this member:Recorded vote on 1 roll call
Disaster Reforestation Act - H.R. 262; Save America's Family Forests Act of 2026 - S. 4442, H.R. 8538; Emergency Conservation Program Improvement Act of 2025 - S. 629.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
APEIRON LABS · lobbying firm or registrant: INNOVATIVE FEDERAL STRATEGIES, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$30,000
Paid to lobbying firm
CitesH.R. 8800· this member:Recorded votes on 21 roll calls
H.R.8800 / S.4784, National Defense Authorization Act, 2027, Title II, all provisions related to ocean sensing capabilities.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BD PERIPHERAL INTERVENTION (CARDIOVASCULAR COALITION) · lobbying firm or registrant: LIBERTY PARTNERS GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
Amount not reported
CitesH.R. 9693· this member:Cosponsored
…ed to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026; H.R. 9693 - Patients First Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
BD PERIPHERAL INTERVENTION (CARDIOVASCULAR COALITION) · lobbying firm or registrant: LIBERTY PARTNERS GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
Amount not reported
CitesH.R. 9693· this member:Cosponsored
…ed to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026; H.R. 9693 - Patients First Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
AZURA VASCULAR CARE (FKA FRESENIUS VASCULAR CARE) (CARDIOVASCULAR COALITION) · lobbying firm or registrant: LIBERTY PARTNERS GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 20, 2026 · issue area: Medicare/Medicaid
Amount not reported
CitesH.R. 9693· this member:Cosponsored
…ed to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026; H.R. 9693 - Patients First Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
AZURA VASCULAR CARE (FKA FRESENIUS VASCULAR CARE) (CARDIOVASCULAR COALITION) · lobbying firm or registrant: LIBERTY PARTNERS GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · amended · posted Oct 20, 2026 · issue area: Health Issues
Amount not reported
CitesH.R. 9693· this member:Cosponsored
…ed to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026; H.R. 9693 - Patients First Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
PUBLIC STRATEGIES 360 ON BEHALF OF CHATHAM COUNTY · lobbying firm or registrant: FREEMAN MATHIS DECISIONS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Natural Resources
$5,000
Paid to lobbying firm
CitesH.R. 9497· this member:Recorded vote on 1 roll call
Issues related to potential placement of beneficial use sand to prevent erosion. H.R. 9497 and S. XX, the Water Resources Development Act of 2026, regarding community directed spending and all provisions related to municipal stormwater management.
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
JINDALEE LITHIUM LIMITED · lobbying firm or registrant: CASSIDY & ASSOCIATES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Natural Resources
$50,000
Paid to lobbying firm
CitesH.R. 1501· this member:Recorded vote on 1 roll call
Mining & Critical Minerals Policy, H.R.1366 - Mining Regulatory Clarity Act of 2025, H.R.4776 - SPEED Act. Mine permitting matters H.R.1501 - Protecting Domestic Mining Act of 2025 permitting reform legislation
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PETROLEUM INSTITUTE · lobbying firm or registrant: AMERICAN PETROLEUM INSTITUTE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Clean Air and Water (quality)
$2,180,000
Spent on own lobbying
CitesH.J.Res. 210· this member:CosponsoredRecorded vote on 1 roll call
H.J.RES. 210 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating t…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PETROLEUM INSTITUTE · lobbying firm or registrant: AMERICAN PETROLEUM INSTITUTE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Clean Air and Water (quality)
$2,180,000
Spent on own lobbying
CitesH.J.Res. 213· this member:SponsoredRecorded vote on 1 roll call
…he Environmental Protection Agency relating to "California State Nonroad Engine Pollution Control Standards; Ocean-Going Vessels At-Berth; Notice of Decision"; H.J.RES. 213 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule issued by the Environmental Protection Agency relating to t…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PETROLEUM INSTITUTE · lobbying firm or registrant: AMERICAN PETROLEUM INSTITUTE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Energy/Nuclear
$2,180,000
Spent on own lobbying
CitesH.R. 8330· this member:Cosponsored
…Act; HR 5301 PIPES Act of 2025; HR 6529 Protecting Families from AI Data Center Energy Costs Act; HR 6633 High-Capacity Grid Act; HR 7831 License to Drill Act; HR 8330 Stop Climate Shakedowns Act of 2026; HR 9338 Pipeline Safety Authorization Act of 2026; HR 9340 Ratepayer Protection Act (provisions relating to definitions un…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PETROLEUM INSTITUTE · lobbying firm or registrant: AMERICAN PETROLEUM INSTITUTE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Energy/Nuclear
$2,180,000
Spent on own lobbying
CitesH.R. 9340· this member:Recorded vote on 1 roll call
…; HR 6633 High-Capacity Grid Act; HR 7831 License to Drill Act; HR 8330 Stop Climate Shakedowns Act of 2026; HR 9338 Pipeline Safety Authorization Act of 2026; HR 9340 Ratepayer Protection Act (provisions relating to definitions under the bill); S 4340 Stop Climate Shakedowns Act of 2026; S 5653 A bill to prescribe permitting…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN PETROLEUM INSTITUTE · lobbying firm or registrant: AMERICAN PETROLEUM INSTITUTE
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$2,180,000
Spent on own lobbying
CitesH.R. 8800· this member:Recorded votes on 21 roll calls
HR 8800 National Defense Authorization Act of 2027 (provisions relating to restricting stock buybacks for companies that contract with the Dept. of War); S 4784 Milita…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVARTIS · lobbying firm or registrant: NOVARTIS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$840,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded vote on 1 roll call
…s, and Extensions Act, 2026 Funding for FDA - FY 2026 Appropriations Federal Budget H.R. 1: One Big Beautiful Bill Act (P.L. 119-21) FY 2027 President's Budget H.R. 6500: Continuing Appropriations and Extensions Act, 2027 (Public Law 119-103)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVARTIS · lobbying firm or registrant: NOVARTIS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$840,000
Spent on own lobbying
CitesH.R. 8800· this member:Recorded votes on 21 roll calls
…Rare Pediatric Disease Priority Review Voucher program policies Most Favored Nation (MFN) policy Clinical trial data in China S.3788: CLEAR Labels Act S. 4784/H.R. 8800: National Defense Authorization Act for Fiscal Year 2027
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) · lobbying firm or registrant: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Budget/Appropriations
$120,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded vote on 1 roll call
HR 6500, the Continuing Appropriations and Extensions Act, 2027; HR 9495, FY2027 appropriations for DOD, specifically provisions related to medical research; HR 9260,…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) · lobbying firm or registrant: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$120,000
Spent on own lobbying
CitesH.R. 6500· this member:Recorded vote on 1 roll call
HR 6500, the Continuing Appropriations and Extensions Act, 2027; HR 7173, Follow the Science Act; HR 9495, FY2027 appropriations for DOD, specifically provisions relat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CHARTER COMMUNICATIONS INC · lobbying firm or registrant: CHARTER COMMUNICATIONS, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Communications/Broadcasting/Radio/TV
$2,230,000
Spent on own lobbying
CitesH.R. 8800· this member:Recorded votes on 21 roll calls
…raft of Memory Chip Competitiveness Assessment Act of 2026, all provisions. H.R. 9151 Advancing American Wi-Fi Against Foreign Adversaries Act, all provisions. H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027, provisions related to spectrum. S. 4784 - National Defense Authorization Act for Fiscal Year 2027, p…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN VASCULAR ACCESS, LLC (CARDIOVASCULAR COALITION) · lobbying firm or registrant: LIBERTY PARTNERS GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
Amount not reported
CitesH.R. 9693· this member:Cosponsored
…to peripheral arterial disease and other cardiovascular issues; H.R. 307 - ARC Act of 2025; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024; H.R. 9693 - Patients First Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
AMERICAN VASCULAR ACCESS, LLC (CARDIOVASCULAR COALITION) · lobbying firm or registrant: LIBERTY PARTNERS GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
Amount not reported
CitesH.R. 9693· this member:Cosponsored
…to peripheral arterial disease and other cardiovascular issues; H.R. 307 - ARC Act of 2025; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024; H.R. 9693 - Patients First Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
ANGIOSAFE (CARDIOVASCULAR COALITION) · lobbying firm or registrant: LIBERTY PARTNERS GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Medicare/Medicaid
Amount not reported
CitesH.R. 9693· this member:Cosponsored
…ted to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026;H.R. 9693 - Patients First Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
ANGIOSAFE (CARDIOVASCULAR COALITION) · lobbying firm or registrant: LIBERTY PARTNERS GROUP, LLC
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
Amount not reported
CitesH.R. 9693· this member:Cosponsored
…ed to peripheral arterial disease and other cardiovascular issues; H.R.307 - ARC Act of 2025; H.R.7863 - Promoting Fairness for Medicare Providers Act of 2026; H.R. 9693 - Patients First Act of 2026
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing